Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.33 |
| ▸ | PPARA | Q07869 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.32 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.30 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3455207 | 0.81 | — | — | |
| SCHEMBL1191660 | 0.78 | MGLL (0.36) | — | |
| SCHEMBL1191141 | 0.77 | CA1 (0.47) | GSK3BADKSOS1PSDGPR84 | |
| SCHEMBL517925 | 0.76 | CA1 (0.50) | — | |
| SCHEMBL5953116 | 0.73 | ALDH1A1 (0.36) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL20019327 | 0.73 | PPARG (0.36) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL8512846 | 0.72 | PPARG (0.33) | PPARGPPARACYP2C9CYP2C19PPARD | |
| SCHEMBL535000 | 0.72 | KIF11 (0.47) | MEN1KMT2A | |
| SCHEMBL11969988 | 0.72 | KIF11 (0.47) | MEN1KMT2A | |
| SCHEMBL16819113 | 0.71 | KDM4E (0.44) | CYP2C9CYP2C19MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9871213-B2 | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2018-01-16 | — | — | US | disclosed |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-9403849-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2015-11-12 | — | — | US | disclosed |
| US-8674141-B2 | Organic electroluminescent device and boric acid and borinic acid derivatives used therein | MERCK PATENT GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | BTD, ERG, OR10J3 | PPARG 2580/4885PPARA 2616/4885CYP2C9 1754/4885 |
| US-20160322570-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | OR10J3, BTD, ERG | PPARG 2594/4885PPARA 2385/4885CYP2C9 2395/4885 |
| US-20150322091-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | BTD, ERG, OR10J3 | PPARG 2580/4885PPARA 2616/4885CYP2C9 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.